Temprian Therapeutics Inc
Advertisement
Temprian Therapeutics is a Chicago-based biotech company that specializes in developing a groundbreaking treatment for vitiligo, a chronic autoimmune disease that causes patches of skin to lose pigmentation. With a team of dedicated doctors and business leaders, Temprian Therapeutics aims to create a safe and effective solution for vitiligo by utilizing genetically modified DNA plasmids to reverse the debilitating immune response associated with the disease.
Founded as a spin-off from Northwestern University, Temprian Therapeutics is built upon over 25 years of research in gene therapies, autoimmune diseases, and dermatology. Led by Professor Caroline Le Poole, a pioneer in identifying vitiligo as an autoimmune disease, the company's platform technology not only targets vitiligo but also holds potential for addressing other autoimmune conditions such as Hashimoto's Disease and Alopecia Areata.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
